Market Overview

MassRoots CEO Ousted By Board

MassRoots CEO Ousted By Board

Ever since MassRoots Inc (OTC: MSRT) acquired CannaRegs for $12 million in stock, there has been speculation around CEO Isaac Dietrich being replaced.

That chatter intensified Monday, and two sources confirmed to Benzinga that Dietrich was "ousted" by the Board of Directors earlier this morning.

Benzinga also reached out to CannaRegs Co-founder and CEO Amanda Ostrowitz, J.D., who is expected to take over as MassRoots president as part of the deal.

"Everything is up in the air right now," Ostrowitz told Benzinga. "I'm allowing them to do what they need to do. I am not officially a member of MassRoots yet, so it’s not my quandary to solve. My duty is to watch and make sure that the best interest of CannaRegs is what I focus on."

"The deal with MassRoots is not closed yet, so I remain focused on CannaRegs. We are doing great, so we want to keep our heads down and keep doing our job,"Ostrowitz added

Green Market Report's Debra Borchardt tweeted that Scott Kveton will be named the new CEO of MassRoots, although Benzinga was not able to confirm.

Shares of the micro-cap OTC stock were trading down about 12 percent at $0.37 a share on Monday afternoon.

MassRoots has mobile applications that enable consumers to provide community-driven reviews of cannabis strains and products, enabling consumers to make cannabis purchasing decisions.

Related Links:

MassRoots CEO Explains Why 'Critics Are Missing The Point'

Investing In Marijuana: Cannabis Industry Raises Hit $1.8 Billion, Up 150% Year Over Year

Posted-In: Amanda Ostrowitz CannaRegs Isaac Dietric MassRootsNews Management Exclusives Movers Best of Benzinga


Related Articles (MSRT)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Morgan Stanley Says You Should Be Selling Omnicom

Understanding The Implications Of iPhone X Supply Constraints